Caricamento...
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Chimeric antigen receptor (CAR) T-cell therapy engineers T-cells to express a synthetic receptor which redirects effector function to the tumor, to improve efficacy and reduce toxicities associated with conventional treatments, such as radiotherapy and chemotherapy. This approach has proved effectiv...
Salvato in:
| Pubblicato in: | Biologics |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8053711/ https://ncbi.nlm.nih.gov/pubmed/33883875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S291768 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|